Show simple item record

dc.contributor.authorSingh, Kumud K.
dc.contributor.authorHughes, Michael D.
dc.contributor.authorChen, Jie
dc.contributor.authorPhiri, Kelesitse
dc.contributor.authorRousseau, Christine
dc.contributor.authorKuhn, Louise
dc.contributor.authorCoutsoudis, Anna
dc.contributor.authorJackson, J. Brooks
dc.contributor.authorGuay, Laura A.
dc.contributor.authorMusoke, Philippa
dc.contributor.authorMmiro, Francis
dc.contributor.authorSemba, Richard D.
dc.contributor.authorSpector, Stephen A.
dc.date.accessioned2021-12-15T10:34:29Z
dc.date.available2021-12-15T10:34:29Z
dc.date.issued1999
dc.identifier.citationAchan, J., Tibenderana, J. K., Kyabayinze, D., Mangen, F. W., Kamya, M. R., Dorsey, G., ... & Talisuna, A. O. (2009). Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trial. Bmj, 339.doi:10.1136/bmj.b2763en_US
dc.identifier.other10.1136/bmj.b2763
dc.identifier.urihttps://nru.uncst.go.ug/xmlui/handle/123456789/577
dc.description.abstractBackground—HIV-1 mother-to-child transmission (MTCT) remains an important route of infection in sub-Saharan Africa. Methods—Genetic variants in CCR5 promoter, CCR2, CX3CR1, and Stromal cell-derived factor-1 (SDF-1) genes were determined in 980 infants from sub-Saharan Africa using real-time polymerase chain reaction to determine association with MTCT. Results—In antiretroviral-naive mother–infant pairs (n = 637), CCR5 promoter polymorphisms at positions 59029: A allele vs. G/G [odds ratio (OR): 1.61, 95% confidence interval (CI): 1.04 to 2.48; P = 0.032] and 59356: T allele vs. C/C (OR: 0.63, 95% CI: 0.41 to 0.96; P = 0.033) and CCR2-180: G allele vs. A/A (OR: 3.32, 95% CI: 1.13 to 9.73; P = 0.029) were associated with risk of MTCT. Treatment of HIV-1–infected mothers and infants with single-dose nevirapine or perinatal zidovudine altered but did not eliminate the association of genetic variants with MTCT. Conclusions—CCR5 promoter, CCR2, and CX3CR1 polymorphisms were associated with risk of MTCT likely through their role as an HIV-1 coreceptor or by modulating the early immune response. genetics may continue to alter MTCT when short-course interventions that only partially suppress virus are used. These findings will need to be confirmed in validation cohorts with a large number of infected infants.en_US
dc.language.isoenen_US
dc.publisherJournal of acquired immune deficiency syndromesen_US
dc.subjectMother-to-child transmissionen_US
dc.subjectHIV-1en_US
dc.subjectChemokine/chemokine receptor genotypesen_US
dc.subjectAntiretroviralsen_US
dc.titleAssociations of Chemokine Receptor Polymorphisms With HIV-1 Mother-to-Child Transmission in Sub-Saharan Africa: Possible Modulation of Genetic Effects by Antiretroviralsen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record